Human periosteum-derived cells combined with superporous hydroxyapatite blocks used as an osteogenic bone substitute for periodontal regenerative therapy: an animal implantation study using nude mice.

BACKGROUND: A superporous (85%) hydroxyapatite (HA) block was recently developed to improve osteoconductivity, but it was often not clinically successful when used to treat periodontal osseous defects. The primary purpose of this study is to develop a clinically applicable tissue-engineered bone substitute using this HA block and human alveolar periosteum-derived cells. METHODS: Commercially available superporous HA blocks were acid treated and subjected to a three-dimensional (3D) culture for periosteal cell cultivation. Cells in the pore regions of the treated HA block were observed on the fracture surface by scanning electron microscopy. After osteogenic induction, the cell-HA complexes were implanted subcutaneously in nude mice. Osteoid formation was histologically evaluated. RESULTS: Acid treatment enlarged the interconnections among pores, resulting in the deep penetration of periosteal cells. Under these conditions, cells were maintained for >2 weeks without appreciable cell death in the deep pore regions of the HA block. The cell-HA complexes that received in vitro osteogenic induction formed osteoids in pore regions of the treated HA blocks in vivo. In contrast, most pore regions in the non-pretreated, cell-free HA blocks that were evaluated in vivo remained cell free. CONCLUSIONS: Our findings suggest that an acid-treated HA block could function as a better scaffold for the 3D high-density culture of human periosteal cells in vitro, and this cell-HA complex had significant osteogenic potential at the site of implantation in vivo. Compared with the cell-free HA block, our cell-HA complex using periosteal cells, which are the most accessible for clinical periodontists, showed promising results as a bone substitute in periodontal regenerative therapy.

Bone regeneration in sinus lifts: comparing tissue-engineered bone and iliac bone.

Lifting of the sinus floor is a standard procedure for bony augmentation that enables dental implantation. Although cultivated skin and mucosal grafts are often used in plastic and maxillofacial surgery, tissue-engineered bone has not achieved the same success. We present the clinical results of dental implants placed after the insertion of periosteum-derived, tissue-engineered bone grafts in sinus lifts. Periosteal cells were isolated from biopsy specimens of periosteum, resuspended and cultured. The cell suspension was soaked in polymer fleeces. The cell-polymer constructs were transplanted by sinus lift 8 weeks after harvesting. The patients (n=35) had either one or both sides operated on. Seventeen had a one-stage sinus lift with simultaneous implantation (54 implants). In 18 patients the implants were inserted 3 months after augmentation (64 implants). Selected cases were biopsied. A control group (41 patients: one stage=48 implants, two stage=135 implants) had augmentation with autologous bone only. They were followed up clinically and radiologically for at least 24 months. Both implants and augmentation were significantly more successful in the control group. Failure of augmentation of the tissue-engineered bone was more common after large areas had been augmented. Eleven implants were lost in the study group and only one in the control group. Lifting the sinus floor with autologous bone is more reliable than with tissue-engineered transplants. Although lamellar bone can be found in periosteum-derived, tissue-engineered transplants, the range of indications must be limited.

Autoinjerto conjuntival de células límbicas para el tratamiento del pterigion, una alternativa para disminuir la recurrencia / Conjuctival autograft of limbic cells in treatment of pterygium, an option to decrease recurrence

Se estudió el uso del autoinjerto conjuntival de células límbicas para el tratamiento quirúrgico del pterigion simple, así como las complicaciones derivadas sobre el uso de esta técnica con el objetivo de mejorar la recurrencia del pterigion. Se realizó la técnica de autoinjerto conjuntival de células límbicas en 144 pacientes que presentaban pterigion simple con una invasión grado III y 10,1 por ciento grado IV. El 68 por ciento se presentó en el ojo derecho y el 32 por ciento en el ojo izquierdo. Se obtuvo un éxito de la operación en el 97,3 por ciento y solo el 2,7 por ciento presentó recurrencia. La complicación más frecuente fue un granuloma que continuó con el tratamiento de esteroide durante 3 meses y se resolvió de forma espontánea.

Use of conjunctival autograft of limbic cells was studied for surgical treatment of simple pterygium, as well as derived complications on use of this technique to improve pterygium recurrence. Technique of conjunctival autograft of limbic cells was applied in 144 patients presenting with simple pterygium with grade III and 10.1 invasion. Sixty eight percentage (68 percent) was present in right eye, and 32 percent in left eye. We had a successful surgery in 97.3 percent, and only 2.7 percent presenting with recurrence. More frequent complication was a granuloma treated with steroids for 3 months, and resolving in a spontaneous way.

Autoinjerto conjuntival de células límbicas para el tratamiento del pterigion, una alternativa para disminuir la recurrencia / Conjuctival autograft of limbic cells in treatment of pterygium, an option to decrease recurrence

Se estudió el uso del autoinjerto conjuntival de células límbicas para el tratamiento quirúrgico del pterigion simple, así como las complicaciones derivadas sobre el uso de esta técnica con el objetivo de mejorar la recurrencia del pterigion. Se realizó la técnica de autoinjerto conjuntival de células límbicas en 144 pacientes que presentaban pterigion simple con una invasión grado III y 10,1 por ciento grado IV. El 68 por ciento se presentó en el ojo derecho y el 32 por ciento en el ojo izquierdo. Se obtuvo un éxito de la operación en el 97,3 por ciento y solo el 2,7 por ciento presentó recurrencia. La complicación más frecuente fue un granuloma que continuó con el tratamiento de esteroide durante 3 meses y se resolvió de forma espontánea(AU)

Use of conjunctival autograft of limbic cells was studied for surgical treatment of simple pterygium, as well as derived complications on use of this technique to improve pterygium recurrence. Technique of conjunctival autograft of limbic cells was applied in 144 patients presenting with simple pterygium with grade III and 10.1 invasion. Sixty eight percentage (68 percent) was present in right eye, and 32 percent in left eye. We had a successful surgery in 97.3 percent, and only 2.7 percent presenting with recurrence. More frequent complication was a granuloma treated with steroids for 3 months, and resolving in a spontaneous way(AU)

Effects of periodontal cell grafts and enamel matrix proteins on the implant-connective tissue interface: a pilot study in the minipig.

We have developed an experimental model to help identify and characterize factors necessary for periodontal connective tissue attachment formation on dental implants. In this pilot study, we report the effect of autogenous periodontal cell grafts, with and without the a pplication of enamel matrix derivative (EMD), on the implant-connective tissue interface. Periodontal ligament (PDL) and gingival connective tissue (GCT) cultures were established from an adult minipig. Implants were placed in osteotomies prepared with exaggerated countersinks that served as recipient sites for autogenous cell grafts in bilateral edentulated posterior mandibular sextants. In addition, 1 side received an application of EMD before placement of the autogenous cell grafts. A bioabsorbable membrane covering the coronal portion of the implants was placed before closure. After 8 weeks, quantitative histomorphometric and qualitative light microscopic analyses revealed that the implants that received gelatin vehicle alone were surrounded by bone, whereas the implants that received GCT cell grafts were mostly surrounded by fibrous connective tissue. In contrast, implants that received PDL cells without the application of EMD demonstrated good bone contact, but strands of epithelium were observed in the implant-connective tissue interface. Implants that received PDL cells and EMD also had good bone contact but without evidence of epithelium. A cementum-like interface was not observed in any of the groups. Results of this pilot study suggest that EMD and the type of cell populations present in the implant wound-healing environment may alter the implant-connective tissue interface.

Preparation and in vivo testing of porous alumina ceramics for cell carrier applications.

Microporous alumina was used to develop implantable cell carriers shaped as a hollow-sphere with a central opening to allow ingrowth of vascularised tissues. The carriers were produced by suspending the ceramic raw materials in water, homogenising and dropping the resulting slurry onto a heated plate (hot plate moulding, HPM). Morphological characteristics of the cell carriers were investigated by SEM and optical microscopy. Produced carriers had an average diameter of 4.9 mm. The material was highly porous (56 +/- 8%). For in vivo testing the cell carriers were implanted into abdominal wall of Zur: SIV rats for up to 50 weeks and investigated by light microscopy, SEM and TEM. The surface of the hollow carriers was in close contact with unirritated muscle tissue; no inflammation or capsule formation was observed. Loose connective tissue had grown into the hollow cell carrier, and after prolonged implantation >20 weeks adipocytes were observed. The absence of scar tissue formation around the implant and the vitality within the cavity of the hollow carriers indicate that porous alumina may be used for cell transplantation devices.